LakeShore Biopharma Co., Ltd: eps_basic
| Value | {"per": "shares", "amount": -0.23, "concept": "us-gaap:EarningsPerShareBasic", "currency": "USD"} |
|---|---|
| Period | 2022-04-01 – 2023-03-31 |
| Status | superseded |
| Entity | LakeShore Biopharma Co., Ltd |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/535f452c-ea5e-46c9-8f3a-ac932ee29961
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-23-060012Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946399/eps-basic/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/535f452c-ea5e-46c9-8f3a-ac932ee29961
History
- supersedes {"per": "shares", "amount": -1.56, "concept": "us-gaap:EarningsPerShareBasic", "currency": "CNY"} (evidence 0001213900-23-060012)